HIGHLIGHTS
- who: August and collaborators from the New University of Lisbon, Portugal Dalian Medical University, China have published the paper: Nanoparticle-based immunotherapy of pancreatic cancer, in the Journal: (JOURNAL)
- what: The major reason for vaccination failure in PC is the high variability of TAAs, which generally limits the induction of an efficient anti-tumor response, in combination with a largely immunosuppressive TME.
SUMMARY
In addition-despite decades of extensive (clinical) research-the key biological aspects of rapid PC progression, metastasis and therapy resistance remain obscure (Effenberger et_al, 2012; Wang et_al, 2021 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.